Company / Current Assets per Share
ARS Pharmaceuticals, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.91
FY2025
5-year range
$2.10 / $9.14
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
#163 of 210
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s current assets per share of $2.91 is lower than 78% of companies in the Health Care sector (FY2025). Current Assets per Share has fluctuated over the past 6 years, ranging from $2.10 in FY2021 to $134.36 in FY2020.
Based on SEC 10-K filings.
2.91 in FY2025 with a 5-year CAGR of -53.5%.
Improved from $2.47 to $2.91 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.7%
- 5-Year CAGR
- -53.5%
- 10-Year CAGR
- -
Sector benchmark
-98.3% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 16.1% year-over-year.
- Ranks #163 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.91 | -16.1% |
| FY2024 | $3.47 | +40.6% |
| FY2023 | $2.47 | -73.0% |
| FY2022 | $9.14 | +334.7% |
| FY2021 | $2.10 | -98.4% |
| FY2020 | $134.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026